LATEST TWEETS

#RRI will be fundamental in achieving the goals set out in the European Green Deal for the European Union (EU) and its citizens. #SeeRRI is supporting the plastic industries in Lower Austria in their quest for a CO2-neutral economy.
#H2020 #CitizenScience #policymakers #CO2

Fighting AMR is a public health priority that requires a collaborative global approach across sectors. @light4lungs is set to develop an alternative to standard treatments.
@light4lungs #FET #Horizon2020 #IQSbarcelona #Photobiology #AntibioticResistance #AMR #Policymakers

ABOUT US
Follow us:      

WeDo is a Barcelona-based company open to the world, with a small, highly-efficient and proactive team. You can find us and our bios in LinkedIn but you can also learn a bit more about us here, and we can meet up to show you more.

Select Page
Volver

NUVATERA Retos Colaboración

Oct 8, 2018 | Projects

Project
Funded by

Title: DESARROLLO DE UNA NUEVA VACUNA TERAPÉUTICA CONTRA EL VIH (NUVATERA)
Length: 3 years
Leader: AELIX Therapeutics SL
Consortium members: Fundació Privada Institut de Recerca de la Sida-Caixa, Fundació LLuita contra la Sida.
Funded by: Ministry of Economy and Business in Spain
Total budget: 2 821 585 euro
Total funding: 2 479 089 euro
Project Website: N/A

About: the project aims at further developing a therapeutic strategy against HIV.

WeDo: members of the Project Management office, assisting the consortium in the strategic front, as well as in the administrative and financial follow-up, the reporting, and the project communication.